Literature DB >> 20709003

Polio vaccines and polio immunization in the pre-eradication era: WHO position paper--recommendations.

.   

Abstract

This article presents the WHO recommendations on the use of polio vaccines excerpted from the recently published Polio vaccines and polio immunization in the pre-eradication era: WHO position paper. This document replaces the WHO position paper entitled Introduction of inactivated poliovirus vaccine into oral poliovirus vaccine-using countries published in the Weekly Epidemiological Record in July 2003. Footnotes to this paper provide a limited number of core references; their abstracts as well as a more comprehensive list of references may be found at http://www.who.int/immunization/documents/positionpapers/en/index.html. Grading tables which assess the quality of scientific evidence for key conclusions are also available through this link and are referenced in the position paper. In accordance with its mandate to provide guidance to Member States on health policy matters, WHO issues a series of regularly updated position papers on vaccines and combinations of vaccines against diseases that have an international public health impact. These papers are concerned primarily with the use of vaccines in large-scale immunization programmes; they summarize essential background information on diseases and vaccines, and conclude with WHO's current position on the use of vaccines in the global context. This updated paper reflects the recent recommendations of WHO's Strategic Advisory Group of Experts on immunization, or SAGE.
Copyright © 2010. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20709003     DOI: 10.1016/j.vaccine.2010.08.023

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  6 in total

Review 1.  Advances in the design and development of SARS-CoV-2 vaccines.

Authors:  Xue-Liang Peng; Ji-Si-Yu Cheng; Hai-Lun Gong; Meng-Di Yuan; Xiao-Hong Zhao; Zibiao Li; Dai-Xu Wei
Journal:  Mil Med Res       Date:  2021-12-16

2.  Human enterovirus surveillance in the Slovak Republic from 2001 to 2011.

Authors:  C Klement; R Kissova; V Lengyelova; D Stipalova; Z Sobotova; J M D Galama; S Bopegamage
Journal:  Epidemiol Infect       Date:  2013-03-18       Impact factor: 2.451

3.  3-Self behavior modification programs base on the PROMISE Model for clients at metabolic risk.

Authors:  Ungsinun Intarakamhang
Journal:  Glob J Health Sci       Date:  2011-12-29

4.  Prevention and assessment of infectious diseases among children and adult migrants arriving to the European Union/European Economic Association: a protocol for a suite of systematic reviews for public health and health systems.

Authors:  Kevin Pottie; Alain D Mayhew; Rachael L Morton; Christina Greenaway; Elie A Akl; Prinon Rahman; Dominik Zenner; Manish Pareek; Peter Tugwell; Vivian Welch; Joerg Meerpohl; Pablo Alonso-Coello; Charles Hui; Beverley-Ann Biggs; Ana Requena-Méndez; Eric Agbata; Teymur Noori; Holger J Schünemann
Journal:  BMJ Open       Date:  2017-09-11       Impact factor: 2.692

Review 5.  Strategies to Develop a Mucosa-Targeting Vaccine against Emerging Infectious Diseases.

Authors:  Fengling Feng; Ziyu Wen; Jiaoshan Chen; Yue Yuan; Congcong Wang; Caijun Sun
Journal:  Viruses       Date:  2022-03-03       Impact factor: 5.048

6.  Immunogenicity of a Candidate DTacP-sIPV Combined Vaccine and Its Protection Efficacy against Pertussis in a Rhesus Macaque Model.

Authors:  Xiaoyu Wang; Na Gao; Jiana Wen; Jingyan Li; Yan Ma; Mingbo Sun; Jiangli Liang; Li Shi
Journal:  Vaccines (Basel)       Date:  2021-12-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.